CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Recruiting

Phase 1

CD64 CAR TCD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Sponsor:

University of Colorado, Denver

Code:

NCT07347418

Conditions

Refractory Acute Myeloid Leukemia (AML)

Relapsed Acute Myeloid Leukemia (AML)

Myelodysplastic Syndrome

AML (Acute Myeloid Leukemia)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CD64 CAR T Cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-09. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-06-29.